Stocks To Buy Today: TVS Motor, Prestige Estate, Zydus Among Others

Advertisement
Read Time: 3 mins
TVS Motor Ltd., Prestige Estates Projects Ltd., and Zydus Lifesciences Ltd. are among the top picks. (Photo source: Envato) 

Several stocks have received buy recommendations for Tuesday's trading session, with TVS Motor Co., Prestige Estates Projects Ltd., and Zydus Lifesciences Ltd. among top picks.

Analysts Brijesh Ail from IDBI Capital and Aditya Arora from Adlytick.in gave their insights to NDTV Profit.

TVS Motor

Brijesh Ail recommends buying TVS Motor stock at the current market price of Rs 2,790, with a target price of Rs 2,850 and a stop loss at Rs 2,745. The stock is expected to perform well in the near term.

Advertisement

Out of 32 analysts tracking the company, 24 have a 'buy' call, nine have a 'hold' call and nine have a 'sell' call on the stock. The average 12-month analysts' consensus price target implies a downside of 2%.

Container Corp.

Ail also suggests buying Container Corporation of India Ltd. at Rs 685, with a target price of Rs 710 and a stop loss at Rs 677.

Advertisement

Out of 22 analysts tracking the company, 12 have a 'buy' call, three have a 'hold' call and seven suggest a 'sell', according to Bloomberg. The average 12-month analysts' consensus price target implies a downside of 18.3%.

Prestige Estate

Prestige Estates Projects Ltd. has a 'buy' recommendation from Ail, at Rs 1,315, targeting Rs 1,350 and a stop loss at Rs 1,298.

Advertisement

Out of 20 analysts tracking the company on Bloomberg, 17 have a 'buy' call, one recommends a 'hold' and two suggest a 'sell'. The average 12-month consensus price target implies a downside of 29.3%.

Fortis Healthcare

Aditya Arora recommends buying Fortis Healthcare Ltd. at Rs 675.20, with a target price range of Rs 705-735 and a stop loss at Rs 645. The stock is expected to see a positive movement.

Out of 15 analysts tracking the company, 14 have a 'buy' call and one has a 'sell' call on the stock. The average 12-month analysts' consensus price target implies a downside of 10.2%.

Zydus Lifesciences 

Arora also suggests buying Zydus Lifesciences Ltd. at Rs 886.55, with a target price range of Rs 912-920 and a stop loss at Rs 860.

Advertisement

Out of 33 analysts tracking the company, 17 have a 'buy' call, 10 have a 'hold' call and six have a 'sell' call, according to Bloomberg. The average 12-month analysts' consensus price target implies a downside of 21.2%.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Loading...